CTIC logo

CTI BioPharma (CTIC) Cash From Financing

CTIC Annual CFF

$120.02 M
+$22.08 M+22.54%

31 December 2022

CTIC Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CTIC Quarterly CFF

$9.63 M
-$3.71 M-27.82%

31 March 2023

CTIC Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CTIC TTM CFF

$68.22 M
-$51.80 M-43.16%

31 March 2023

CTIC TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CTIC Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+22.5%-84.3%-56.8%
3 y3 years+2240.6%-83.4%+27.0%
5 y5 years+207.9%-85.1%+1316.7%

CTIC Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-29.2%-93.3%-75.3%

CTI BioPharma Cash From Financing History

DateAnnualQuarterlyTTM
Mar 2023
-
$9.63 M(-27.8%)
$68.22 M(-43.2%)
Dec 2022
$120.02 M(+22.5%)
$13.35 M(+1205.8%)
$120.02 M(+12.3%)
Sept 2022
-
$1.02 M(-97.7%)
$106.86 M(-28.6%)
June 2022
-
$44.22 M(-28.0%)
$149.74 M(-5.2%)
Mar 2022
-
$61.43 M(>+9900.0%)
$157.89 M(+61.2%)
Dec 2021
$97.94 M(+60.4%)
$188.00 K(-99.6%)
$97.94 M(-5.5%)
Sept 2021
-
$43.90 M(-16.2%)
$103.68 M(+77.4%)
June 2021
-
$52.37 M(+3419.4%)
$58.45 M(+1167.2%)
Mar 2021
-
$1.49 M(-74.9%)
$4.61 M(-92.4%)
Dec 2020
$61.07 M(-1189.2%)
$5.93 M(-544.9%)
$61.07 M(+14.0%)
Sept 2020
-
-$1.33 M(-9.4%)
$53.58 M(0.0%)
June 2020
-
-$1.47 M(-102.5%)
$53.58 M(-0.3%)
Mar 2020
-
$57.95 M(-3807.4%)
$53.72 M(-1058.1%)
Dec 2019
-$5.61 M(-108.8%)
-$1.56 M(+17.3%)
-$5.61 M(+20.4%)
Sept 2019
-
-$1.33 M(0.0%)
-$4.66 M(+40.5%)
June 2019
-
-$1.33 M(-3.3%)
-$3.31 M(+34.1%)
Mar 2019
-
-$1.38 M(+125.2%)
-$2.47 M(-103.9%)
Dec 2018
$63.49 M(+62.9%)
-$612.00 K(-6900.0%)
$63.49 M(-2.5%)
Sept 2018
-
$9000.00(-101.8%)
$65.09 M(+1.7%)
June 2018
-
-$491.00 K(-100.8%)
$64.03 M(-39.3%)
Mar 2018
-
$64.58 M(+6450.2%)
$105.54 M(+170.8%)
Dec 2017
$38.98 M(-629.2%)
$986.00 K(-193.9%)
$38.98 M(+12.0%)
Sept 2017
-
-$1.05 M(-102.6%)
$34.81 M(+2.3%)
June 2017
-
$41.02 M(-2179.9%)
$34.04 M(-474.5%)
Mar 2017
-
-$1.97 M(-38.1%)
-$9.09 M(+23.4%)
Dec 2016
-$7.37 M(-104.8%)
-$3.18 M(+74.9%)
-$7.37 M(-107.4%)
Sept 2016
-
-$1.82 M(-13.9%)
$99.65 M(-14.9%)
June 2016
-
-$2.11 M(+748.6%)
$117.15 M(-24.3%)
Mar 2016
-
-$249.00 K(-100.2%)
$154.81 M(+1.8%)
Dec 2015
$152.02 M(+322.0%)
$103.83 M(+562.0%)
$152.02 M(+80.1%)
Sept 2015
-
$15.69 M(-55.9%)
$84.39 M(+22.9%)
June 2015
-
$35.54 M(-1270.2%)
$68.65 M(+106.8%)
Mar 2015
-
-$3.04 M(-108.4%)
$33.20 M(-7.9%)
Dec 2014
$36.03 M(-38.9%)
$36.20 M(<-9900.0%)
$36.03 M(+4.1%)
Sept 2014
-
-$57.00 K(-167.9%)
$34.62 M(-29.9%)
June 2014
-
$84.00 K(-140.8%)
$49.40 M(+0.6%)
Mar 2014
-
-$206.00 K(-100.6%)
$49.13 M(-16.7%)
Dec 2013
$58.97 M(-32.4%)
$34.80 M(+136.3%)
$58.97 M(-25.1%)
Sept 2013
-
$14.72 M(-7973.8%)
$78.78 M(+1.0%)
June 2013
-
-$187.00 K(-101.9%)
$77.99 M(-19.6%)
Mar 2013
-
$9.64 M(-82.4%)
$96.94 M(+11.2%)
Dec 2012
$87.22 M(+0.2%)
$54.61 M(+292.1%)
$87.22 M(+116.0%)
Sept 2012
-
$13.93 M(-25.8%)
$40.37 M(-16.8%)
June 2012
-
$18.77 M(<-9900.0%)
$48.55 M(+21.3%)
Mar 2012
-
-$87.00 K(-101.1%)
$40.03 M(-54.0%)
Dec 2011
$87.00 M(+75.0%)
$7.76 M(-64.9%)
$87.00 M(-11.5%)
Sept 2011
-
$22.11 M(+115.7%)
$98.34 M(+139.0%)
June 2011
-
$10.25 M(-78.1%)
$41.15 M(-40.4%)
Mar 2011
-
$46.88 M(+145.4%)
$69.09 M(+39.0%)
Dec 2010
$49.72 M(-47.5%)
$19.11 M(-154.4%)
$49.72 M(+59.4%)
Sept 2010
-
-$35.09 M(-191.9%)
$31.19 M(-76.0%)
June 2010
-
$38.19 M(+38.8%)
$129.78 M(+3.4%)
Mar 2010
-
$27.52 M(+4701.9%)
$125.50 M(+32.4%)
DateAnnualQuarterlyTTM
Dec 2009
$94.78 M(+28.6%)
$573.00 K(-99.1%)
$94.78 M(-11.2%)
Sept 2009
-
$63.49 M(+87.2%)
$106.78 M(+68.0%)
June 2009
-
$33.91 M(-1157.2%)
$63.56 M(+24.4%)
Mar 2009
-
-$3.21 M(-125.5%)
$51.11 M(-30.7%)
Dec 2008
$73.73 M(-13.0%)
$12.58 M(-37.9%)
$73.73 M(+0.0%)
Sept 2008
-
$20.27 M(-5.6%)
$73.70 M(+2.2%)
June 2008
-
$21.47 M(+10.6%)
$72.14 M(-15.5%)
Mar 2008
-
$19.41 M(+54.6%)
$85.39 M(+0.8%)
Dec 2007
$84.70 M(-17.6%)
$12.55 M(-32.9%)
$84.70 M(+1.0%)
Sept 2007
-
$18.71 M(-46.1%)
$83.85 M(-18.6%)
June 2007
-
$34.72 M(+85.5%)
$102.98 M(+0.3%)
Mar 2007
-
$18.72 M(+59.9%)
$102.67 M(-0.1%)
Dec 2006
$102.74 M(+745.6%)
$11.71 M(-69.1%)
$102.74 M(-28.4%)
Sept 2006
-
$37.84 M(+10.0%)
$143.43 M(+117.7%)
June 2006
-
$34.41 M(+83.1%)
$65.87 M(+111.3%)
Mar 2006
-
$18.79 M(-64.1%)
$31.17 M(+156.6%)
Dec 2005
$12.15 M(-86.3%)
$52.39 M(-231.9%)
$12.15 M(+256.9%)
Sept 2005
-
-$39.72 M(>+9900.0%)
$3.40 M(-96.2%)
June 2005
-
-$294.00 K(+26.2%)
$88.47 M(-0.3%)
Mar 2005
-
-$233.00 K(-100.5%)
$88.78 M(-0.1%)
Dec 2004
$88.89 M(+22.3%)
$43.65 M(-3.8%)
$88.89 M(+96.6%)
Sept 2004
-
$45.35 M(>+9900.0%)
$45.22 M(>+9900.0%)
June 2004
-
$7000.00(-106.1%)
$248.00 K(-99.7%)
Mar 2004
-
-$115.00 K(+310.7%)
$72.78 M(+0.1%)
Dec 2003
$72.70 M(-684.0%)
-$28.00 K(-107.3%)
$72.70 M(-3.6%)
Sept 2003
-
$384.00 K(-99.5%)
$75.45 M(+4.7%)
June 2003
-
$72.54 M(<-9900.0%)
$72.06 M(-669.1%)
Mar 2003
-
-$191.00 K(-107.0%)
-$12.66 M(+1.7%)
Dec 2002
-$12.45 M(-107.3%)
$2.72 M(-190.4%)
-$12.45 M(-7.4%)
Sept 2002
-
-$3.01 M(-75.3%)
-$13.45 M(-202.2%)
June 2002
-
-$12.18 M(<-9900.0%)
$13.16 M(-92.2%)
Mar 2002
-
$20.00 K(-98.8%)
$169.47 M(-0.1%)
Dec 2001
$169.57 M(+0.9%)
$1.72 M(-92.7%)
$169.57 M(-0.8%)
Sept 2001
-
$23.60 M(-83.6%)
$170.88 M(-38.1%)
June 2001
-
$144.13 M(>+9900.0%)
$276.04 M(+112.7%)
Mar 2001
-
$121.10 K(-96.0%)
$129.77 M(-22.7%)
Dec 2000
$167.97 M(+1899.7%)
$3.03 M(-97.6%)
$167.97 M(-3.5%)
Sept 2000
-
$128.75 M(-6134.0%)
$174.14 M(+286.2%)
June 2000
-
-$2.13 M(-105.6%)
$45.09 M(-4.1%)
Mar 2000
-
$38.32 M(+316.5%)
$47.02 M(+459.8%)
Dec 1999
$8.40 M(+600.0%)
$9.20 M(-3166.7%)
$8.40 M(-1033.3%)
Sept 1999
-
-$300.00 K(+50.0%)
-$900.00 K(-169.2%)
June 1999
-
-$200.00 K(-33.3%)
$1.30 M(+8.3%)
Mar 1999
-
-$300.00 K(+200.0%)
$1.20 M(0.0%)
Dec 1998
$1.20 M(-98.2%)
-$100.00 K(-105.3%)
$1.20 M(-96.8%)
Sept 1998
-
$1.90 M(-733.3%)
$37.10 M(+5.1%)
June 1998
-
-$300.00 K(0.0%)
$35.30 M(0.0%)
Mar 1998
-
-$300.00 K(-100.8%)
$35.30 M(-45.8%)
Dec 1997
$65.10 M(+201.4%)
$35.80 M(>+9900.0%)
$65.10 M(+122.2%)
Sept 1997
-
$100.00 K(-133.3%)
$29.30 M(+0.3%)
June 1997
-
-$300.00 K(-101.0%)
$29.20 M(-1.0%)
Mar 1997
-
$29.50 M
$29.50 M
Dec 1996
$21.60 M
-
-

FAQ

  • What is CTI BioPharma annual cash flow from financing activities?
  • What is the all time high annual CFF for CTI BioPharma?
  • What is CTI BioPharma annual CFF year-on-year change?
  • What is CTI BioPharma quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for CTI BioPharma?
  • What is CTI BioPharma quarterly CFF year-on-year change?
  • What is CTI BioPharma TTM cash flow from financing activities?
  • What is the all time high TTM CFF for CTI BioPharma?
  • What is CTI BioPharma TTM CFF year-on-year change?

What is CTI BioPharma annual cash flow from financing activities?

The current annual CFF of CTIC is $120.02 M

What is the all time high annual CFF for CTI BioPharma?

CTI BioPharma all-time high annual cash flow from financing activities is $169.57 M

What is CTI BioPharma annual CFF year-on-year change?

Over the past year, CTIC annual cash flow from financing activities has changed by +$22.08 M (+22.54%)

What is CTI BioPharma quarterly cash flow from financing activities?

The current quarterly CFF of CTIC is $9.63 M

What is the all time high quarterly CFF for CTI BioPharma?

CTI BioPharma all-time high quarterly cash flow from financing activities is $144.13 M

What is CTI BioPharma quarterly CFF year-on-year change?

Over the past year, CTIC quarterly cash flow from financing activities has changed by -$51.80 M (-84.32%)

What is CTI BioPharma TTM cash flow from financing activities?

The current TTM CFF of CTIC is $68.22 M

What is the all time high TTM CFF for CTI BioPharma?

CTI BioPharma all-time high TTM cash flow from financing activities is $276.04 M

What is CTI BioPharma TTM CFF year-on-year change?

Over the past year, CTIC TTM cash flow from financing activities has changed by -$89.67 M (-56.79%)